A Computationally Designed Water-Soluble Variant of a G-Protein-Coupled Receptor: The Human Mu Opioid Receptor

G-protein-coupled receptors (GPCRs) play essential roles in various physiological processes, and are widely targeted by pharmaceutical drugs. Despite their importance, studying GPCRs has been problematic due to difficulties in isolating large quantities of these membrane proteins in forms that retain their ligand binding capabilities. Creating water-soluble variants of GPCRs by mutating the exterior, transmembrane residues provides a potential method to overcome these difficulties. Here we present the first study involving the computational design, expression and characterization of water-soluble variant of a human GPCR, the human mu opioid receptor (MUR), which is involved in pain and addiction. An atomistic structure of the transmembrane domain was built using comparative (homology) modeling and known GPCR structures. This structure was highly similar to the subsequently determined structure of the murine receptor and was used to computationally design 53 mutations of exterior residues in the transmembrane region, yielding a variant intended to be soluble in aqueous media. The designed variant expressed in high yield in Escherichia coli and was water soluble. The variant shared structural and functionally related features with the native human MUR, including helical secondary structure and comparable affinity for the antagonist naltrexone (K d  = 65 nM). The roles of cholesterol and disulfide bonds on the stability of the receptor variant were also investigated. This study exemplifies the potential of the computational approach to produce water-soluble variants of GPCRs amenable for structural and functionally related characterization in aqueous solution.

[1]  H. Attrill,et al.  The role of cholesterol on the activity and stability of neurotensin receptor 1. , 2012, Biochimica et biophysica acta.

[2]  H. Schiöth,et al.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.

[3]  H Kono,et al.  Statistical Theory for Protein Combinatorial Libraries , 2001 .

[4]  Pei Tang,et al.  NMR studies of a channel protein without membranes: Structure and dynamics of water-solubilized KcsA , 2008, Proceedings of the National Academy of Sciences.

[5]  C. K. Surratt,et al.  Mutation of human μ opioid receptor extracellular “disulfide cysteine” residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane , 1999 .

[6]  Vadim Cherezov,et al.  A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.

[7]  Yoko Shibata,et al.  Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form , 2008, Proceedings of the National Academy of Sciences.

[8]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[9]  Marcus Elstner,et al.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.

[10]  Roland L. Dunbrack,et al.  Bayesian statistical analysis of protein side‐chain rotamer preferences , 1997, Protein science : a publication of the Protein Society.

[11]  Bryan L. Roth,et al.  Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.

[12]  R. MacKinnon,et al.  Chemistry of ion coordination and hydration revealed by a K+ channel–Fab complex at 2.0 Å resolution , 2001, Nature.

[13]  Arne Elofsson,et al.  Why are polar residues within the membrane core evolutionary conserved? , 2011, Proteins.

[14]  Werner Braun,et al.  Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..

[15]  C. Inturrisi Clinical Pharmacology of Opioids for Pain , 2002, The Clinical journal of pain.

[16]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J G Saven,et al.  Statistical theory for protein combinatorial libraries. Packing interactions, backbone flexibility, and the sequence variability of a main-chain structure. , 2001, Journal of molecular biology.

[18]  J. M. Perez-Aguilar,et al.  Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor , 2012, Journal of anesthesia & clinical research.

[19]  Alessandro Senes,et al.  Computational design of membrane proteins. , 2011, Current opinion in structural biology.

[20]  A. Milon,et al.  The N-Terminal End Truncated Mu-Opioid Receptor: from Expression to Circular Dichroism Analysis , 2010, Applied biochemistry and biotechnology.

[21]  R. Stevens,et al.  Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets. , 2010, Methods in molecular biology.

[22]  D Eisenberg,et al.  Hydrophobic organization of membrane proteins. , 1989, Science.

[23]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[24]  B. Kieffer,et al.  Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins. , 1999, European journal of biochemistry.

[25]  D. Ferguson,et al.  Molecular docking reveals a novel binding site model for fentanyl at the mu-opioid receptor. , 2000, Journal of medicinal chemistry.

[26]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[27]  Arne Elofsson,et al.  Architecture of helix bundle membrane proteins: An analysis of cytochrome c oxidase from bovine mitochondria , 1997, Protein science : a publication of the Protein Society.

[28]  B. Kuehn Opioid Prescriptions Soar , 2007 .

[29]  J G Saven,et al.  Statistical theory of combinatorial libraries of folding proteins: energetic discrimination of a target structure. , 2000, Journal of molecular biology.

[30]  One-Sun Lee,et al.  Molecular Dynamics Simulation of WSK-3, a Computationally Designed, Water-Soluble Variant of the Integral Membrane Protein KcsA. , 2006, Biophysical journal.

[31]  Aashish Manglik,et al.  Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.

[32]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[33]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[34]  S. Boyault,et al.  Overexpression and role of the ATPase and putative DNA helicase RuvB‐like 2 in human hepatocellular carcinoma , 2007, Hepatology.

[35]  A. Milon,et al.  The Full-Length Mu-Opioid Receptor: A Conformational Study by Circular Dichroism in Trifluoroethanol and Membrane-Mimetic Environments , 2008, Journal of Membrane Biology.

[36]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[37]  Y. Fujiyoshi,et al.  Structure and gating mechanism of the acetylcholine receptor pore , 2003, Nature.

[38]  Christopher M. MacDermaid,et al.  Theoretical and computational protein design. , 2011, Annual review of physical chemistry.

[39]  Thijs Beuming,et al.  A knowledge-based scale for the analysis and prediction of buried and exposed faces of transmembrane domain proteins , 2004, Bioinform..

[40]  Mathias W. Hofmann,et al.  An automated application for deconvolution of circular dichroism spectra of small peptides. , 2007, Analytical biochemistry.

[41]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[42]  Peter B. McGarvey,et al.  Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.

[43]  Nora D Volkow,et al.  Characteristics of opioid prescriptions in 2009. , 2011, JAMA.

[44]  N. Tinel,et al.  A Fluorescent Ligand-Binding Alternative Using Tag-lite® Technology , 2010, Journal of biomolecular screening.

[45]  Jing He,et al.  NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor. , 2012, Biochimica et biophysica acta.

[46]  K. Gawrisch,et al.  Bacterial expression of functional, biotinylated peripheral cannabinoid receptor CB2. , 2006, Protein expression and purification.

[47]  Laxmaiah Manchikanti,et al.  Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. , 2008, Pain physician.

[48]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[49]  B. Monsarrat,et al.  Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. , 2005, Protein expression and purification.

[50]  Jeffery G. Saven,et al.  Computational design of water-soluble analogues of the potassium channel KcsA , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Beyond the detergent effect: a binding site for sodium dodecyl sulfate (SDS) in mammalian apoferritin. , 2012, Acta crystallographica. Section D, Biological crystallography.

[52]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[53]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[54]  Masao Nagasaki,et al.  BFL: a node and edge betweenness based fast layout algorithm for large scale networks , 2009, BMC Bioinformatics.

[55]  A Sali,et al.  Comparative protein modeling by satisfaction of spatial restraints. , 1996, Molecular medicine today.

[56]  Christopher K Surratt,et al.  G protein-coupled receptor structural motifs: relevance to the opioid receptors. , 2005, Current topics in medicinal chemistry.

[57]  B. Kuehn Opioid prescriptions soar: increase in legitimate use as well as abuse. , 2007, JAMA.

[58]  J. Slotte,et al.  Cholesterol interactions with phospholipids in membranes. , 2002, Progress in lipid research.

[59]  J. Changeux,et al.  X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel , 2011, Nature.

[60]  C. K. Surratt,et al.  Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. , 1999, Brain research. Molecular brain research.

[61]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.